XOMA Corporation
Tracked across 3 events · 19 articles · First seen Jan 08, 2026 · Last active Jul 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: XOMA Corporation announced cash dividends for its Series A and Series B Preferred Stock and will redeem all outstanding shares of Preferred Stock. This action is in connection with its pending merger with Auddia Merger Sub, Inc., a subsidiary of Ligand Pharmaceuticals Incorporated. Additionally, XOMA Corporation set a record date for the distribution of contingent value rights (CVRs) to its common stock holders.
Jun 12, 2026 · 7 articles
Business
Impact: Acquired by Ligand; shareholders received $39/share plus CVRs; delisted from Nasdaq.
Jul 14, 2026 · 6 articles
Business
Impact: XOMA Corporation is the proposed acquirer of Generation Bio Co., with Generation Bio shareholders receiving cash and contingent value rights.
Jan 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track XOMA Corporation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard